Nancy A. Thornberry's Insider Trades & SAST Disclosures
Nancy A. Thornberry's most recent trade in Vertex Pharmaceuticals, Inc. was a trade of 1,199 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nancy A. Thornberry.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 1,199 | 1,199 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 398 | 2,035 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,550 | 8,550 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,000 | 11,250 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 18,680 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharmaceuticals, Inc. | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,571 | 1,571 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 501 | 1,637 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges